GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · Equity segment
Company Filings, Explained Simply

AI-powered plain-English analysis of every important corporate announcement — financial results, order wins, dividends, mergers and more. Updated live.

—
Filed today
—
Companies tracked
NSE & BSE
Listed on
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings —

📋 Filing Types Available on ForgeUp Filings Sourced from BSE corporate announcements (equity segment). Companies covered are BSE-listed and most are also listed on NSE. We show only material filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India corporate announcements. More categories will be added over time.
Suven Life Sciences Ltd

Suven Life Sciences Board to Consider Q2 FY27 Unaudited Financial Results

RESULTS ● No Immediate Change LOW RISK
📅 Filed on BSE: 29 Oct 2026, 03:55 PM IST  ·  BSE ID: 06a767bb-e587-41ed-b921-7098b476e398
View Original BSE Filing (PDF)
💡
In Simple Terms
Suven Life Sciences' board will meet on November 5, 2026, to review its financial performance for the last three and six months.
🤖 AI Summary
  • Suven Life Sciences Ltd Board meeting scheduled for Thursday, November 5, 2026.
  • Board to consider and approve unaudited financial results for Q2 and H1 FY27.
  • Results cover the quarter and half year ended September 30, 2026.
  • Trading window closed from October 1, 2026, until 48 hours after results declaration.
👥 What This Means For Shareholders
✅
Action Required
No action is required from shareholders based on this intimation.
👤
Who Is Affected
All shareholders are equally affected as the company prepares to disclose its financial performance, providing updated operational and financial transparency.
🔍
Management Signal
The scheduled board meeting indicates management's adherence to regulatory timelines for financial reporting and transparency.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Board meeting outcome on November 5, 2026 — confirmation of Q2 and H1 FY27 results.
Release of Unaudited Financial Results for Q2 and H1 FY27 — actual financial performance details.
Trading window reopening announcement — 48 hours after results declaration.
LOW RISK This filing is a routine board meeting intimation, presenting no immediate or new risks.
💡 Investor Takeaway
Suven Life Sciences Ltd will hold a Board meeting on November 5, 2026, to approve unaudited financial results for the quarter and half year ended September 30, 2026. The trading window closed from October 1, 2026, and will reopen 48 hours after results declaration.
📅 Company Track Record
Suven Life Sciences Ltd previously reported a consolidated net loss of Rs. (12,761.03) Lakhs for Q1 FY27, as per filings on August 6, 2026. The current intimation sets the stage for the next financial disclosure for the quarter ended September 30, 2026.

Based on publicly available historical data. For context only.

❓ Frequently Asked Questions
When is the next Board Meeting for Suven Life Sciences Ltd?
The next Board of Directors meeting for Suven Life Sciences Ltd is scheduled for Thursday, November 5, 2026.
What is the primary agenda of the upcoming Suven Life Sciences Ltd Board meeting?
The primary agenda of the upcoming Board meeting is to consider and approve the unaudited Financial Results (Standalone and Consolidated) for the quarter and half year ended September 30, 2026.
When did the trading window close for Suven Life Sciences Ltd?
The trading window for Suven Life Sciences Ltd closed from October 1, 2026, and will remain closed up to 48 hours after the declaration of the unaudited Financial Results.

Questions based on this BSE filing only. For information purposes.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.